awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37580148-233797DC-0C21-4291-A1FA-5166ABCA88B6
Q37580148-233797DC-0C21-4291-A1FA-5166ABCA88B6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37580148-233797DC-0C21-4291-A1FA-5166ABCA88B6
Clinical pharmacology of tyrosine kinase inhibitors becoming generic drugs: the regulatory perspective
P2860
Q37580148-233797DC-0C21-4291-A1FA-5166ABCA88B6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37580148-233797DC-0C21-4291-A1FA-5166ABCA88B6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7c5a4baf40c647508a6b49caae2138cd25525336
P2860
Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with pemetrexed in patients with advanced solid tumors.